Prostate Cancer - Results from #23780

Androgen deprivation therapy in advanced prostate cancer: Is intermittent therapy the new standard of care? - Abstract March 1, 2013

Targeting the androgen receptor in the management of castration-resistant prostate cancer: Rationale, progress, and future directions - Abstract March 1, 2013

The importance of local control in high-risk locally advanced prostate cancer - Abstract March 1, 2013

Improving prostate cancer detection in veterans through the development of a clinical decision rule for prostate biopsy - Abstract March 1, 2013

Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer - Abstract March 1, 2013

Targeting the apoptosis pathway in prostate cancer - Abstract February 28, 2013

GU Cancers Symposium 2013 - Evolving patterns of metastatic disease in castration resistant prostate cancer reported in clinical trials from 1990 to 2011, by William K. Oh, MD, et al. - Session Highlights February 28, 2013

GU Cancers Symposium 2013 - Poster: Evolving patterns of metastatic disease in castration resistant prostate cancer reported in clinical trials from 1990 to 2011, by William K. Oh, MD, et al. February 28, 2013

Bone-targeting radiopharmaceuticals including radium-223 - Abstract February 27, 2013

Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer - Abstract February 27, 2013

Association between use of β-blockers and prostate cancer-specific survival: A cohort study of 3561 prostate cancer patients with high-risk or metastatic disease - Abstract February 27, 2013

Metabolic syndrome and insulin resistance in patients with prostate cancer treated with androgen deprivation hormone - Abstract February 27, 2013

Prostate cancer and osteoporosis - Abstract February 27, 2013

Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: Comparison with 18F-fluoride uptake - Abstract February 27, 2013

Incidence of prostate, breast, lung and colorectal cancer following new consultation for musculoskeletal pain: A cohort study among UK primary care patients - Abstract February 27, 2013

Fatherhood status and risk of prostate cancer. Nationwide, population-based case-control study - Abstract February 27, 2013

Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance - Abstract February 27, 2013

Androgen deprivation therapy: Evidence-based management of side effects - Abstract February 27, 2013

Osteoporosis knowledge, health beliefs, and healthy bone behaviours in patients on androgen-deprivation therapy (ADT) for prostate cancer - Abstract February 27, 2013

Radiosensitization in prostate cancer: Mechanisms and targets - Abstract February 27, 2013

Page 1190 of 1438